Effect of Pioglitazone on Insulin Resistance and Atherosclerosis in Renal Allograft Recipients Without Diabetes
NCT00598013
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
83
Enrollment
OTHER
Sponsor class
Conditions
Kidney Transplantation
Insulin Resistance
Atherosclerosis
Interventions
DRUG:
Pioglitazone
Sponsor
Yonsei University